SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Reports Unaudited Second Quarter 2019 Financial Results BEIJING, China, August 15, 2019 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the secon]

By | 2019-08-16T12:26:47+00:00 August 16th, 2019|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited Second Quarter 2019 Financial Results

[Sinovac Reports Unaudited Second Quarter 2019 Financial Results BEIJING, China, August 15, 2019 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the secon]

By | 2019-08-16T12:26:53+00:00 August 16th, 2019|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

XIN [Xinyuan Real Estate] 6-K: (Original Filing)

[Xinyuan Real Estate Co., Ltd. Announces Second Quarter 2019 Financial Results BEIJING, China, August 16, 2019 Highlights · First half contract sales of 2019 increased 3.4% to RMB6,676.3 million from RMB6,457.0 million in the first half of 2018. · Contract sales decreased 20.0% to US$507.4 million fr]

XIN [Xinyuan Real Estate] 6-K: Xinyuan Real Estate Co., Ltd. Announces Second Quarter

[Xinyuan Real Estate Co., Ltd. Announces Second Quarter 2019 Financial Results BEIJING, China, August 16, 2019 Highlights · First half contract sales of 2019 increased 3.4% to RMB6,676.3 million from RMB6,457.0 million in the first half of 2018. · Contract sales decreased 20.0% to US$507.4 million fr]

Skip to toolbar